ARDS, HUMAN
Clinical trials for ARDS, HUMAN explained in plain language.
Never miss a new study
Get alerted when new ARDS, HUMAN trials appear
Sign up with your email to follow new studies for ARDS, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung hormone therapy for COVID-19 ARDS trial pulled before start
Disease control TerminatedThis study aimed to see if giving a thyroid hormone (T3) directly into the lungs could help people with severe COVID-19 who needed a breathing machine. The trial was planned for adults with COVID-19 and a serious lung condition called ARDS. However, the study was withdrawn before…
Matched conditions: ARDS, HUMAN
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 17, 2026 03:59 UTC
-
Could a thyroid hormone help ARDS patients breathe easier?
Disease control OngoingThis study tests whether giving a thyroid hormone (T3) directly into the lungs can safely improve oxygen levels and reduce inflammation in people with acute respiratory distress syndrome (ARDS). About 68 adults on ventilators will either receive the hormone or standard care. The …
Matched conditions: ARDS, HUMAN
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 17, 2026 03:57 UTC
-
New ICU pathway aims to save lives of patients with lung failure
Disease control OngoingThis study looks at whether a step-by-step care plan, called TheraPPP, helps doctors better treat patients with severe breathing failure (ARDS). The plan includes using protective ventilation, paralysis, and prone positioning. About 20,000 adults on breathing machines in Alberta …
Matched conditions: ARDS, HUMAN
Phase: NA • Sponsor: University of Calgary • Aim: Disease control
Last updated May 17, 2026 03:55 UTC
-
Stem cells aim to heal lungs after severe COVID-19
Disease control TerminatedThis study tested whether stem cells from healthy donors could help people recover from severe lung damage caused by COVID-19. It was designed for adults who had been on a ventilator but had since improved. The trial was withdrawn before enrolling any participants, so no results …
Matched conditions: ARDS, HUMAN
Phase: PHASE1 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated May 11, 2026 20:39 UTC